Benjamin J. Hindson - 22 Aug 2025 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
President and Chief Scientific Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson
Issuer symbol
TXG
Transactions as of
22 Aug 2025
Net transactions value
-$103,209
Form type
4
Filing time
26 Aug 2025, 16:12:55 UTC
Previous filing
27 May 2025
Next filing
25 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Benjamin J. Hindson filed Form 4 for 10x Genomics, Inc. (TXG) on 26 Aug 2025."

Quick Takeaways

  • This page summarizes Benjamin J. Hindson's Form 4 filing for 10x Genomics, Inc. (TXG).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 26 Aug 2025, 16:12.

What Changed

  • Previous filing in this sequence was filed on 27 May 2025.
  • Current net transaction value: -$103,209.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hindson Benjamin J. President and Chief Scientific Officer, Director 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON /s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson 26 Aug 2025 0001786391

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $103,209 -7,486 -1.7% $13.79 440,888 22 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

President and Chief Scientific Officer

Sponsored